300633 开立医疗
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)0.4396.1934.55415.44214.516
总资产报酬率 ROA (%)0.3244.5253.52312.42411.267
投入资产回报率 ROIC (%)0.3915.4374.14014.36013.229

边际利润分析
销售毛利率 (%)60.87861.98763.78367.71166.866
营业利润率 (%)0.7777.1586.03622.39421.696
息税前利润/营业总收入 (%)3.1665.6864.11220.24119.973
净利润/营业总收入 (%)1.3088.5447.07121.43320.980

收益指标分析
经营活动净收益/利润总额(%)-421.51776.33899.87696.02389.845
价值变动净收益/利润总额(%)11.8101.4373.462-2.7101.393
营业外收支净额/利润总额(%)0.109-0.665-1.137-0.208-0.127

偿债能力分析
流动比率 (X)2.9832.7602.7464.6173.355
速动比率 (X)1.7992.0122.1433.6822.669
资产负债率 (%)26.20825.95927.93416.58422.697
带息债务/全部投入资本 (%)9.2148.14511.7511.8928.800
股东权益/带息债务 (%)960.4801,099.480731.7885,093.5281,016.020
股东权益/负债合计 (%)281.566285.228257.992502.980340.596
利息保障倍数 (X)1.326-3.989-2.215-9.606-11.778

营运能力分析
应收账款周转天数 (天)48.43639.94234.50531.65941.571
存货周转天数 (天)377.127290.539292.342274.978294.299